Amneal Pharmaceuticals Inc. (NYSE:AMRX) Stock Dropped -3.13% Year-To-Date, What Analysts Expect Next? – Marketing Sentinel
Home  »  Technologies   »  Amneal Pharmaceuticals Inc. (NYSE:AMRX) Stock Drop...

Amneal Pharmaceuticals Inc. (NYSE:AMRX) Stock Dropped -3.13% Year-To-Date, What Analysts Expect Next?

In last trading session, Amneal Pharmaceuticals Inc. (NYSE:AMRX) saw 0.33 million shares changing hands with its beta currently measuring 1.28. Company’s recent per share price level of $4.64 trading at $0.03 or 0.65% at ring of the bell on the day assigns it a market valuation of $1.39B. That closing price of AMRX’s stock is at a discount of -60.56% from its 52-week high price of $7.45 and is indicating a premium of 16.16% from its 52-week low price of $3.89. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.63 million shares which gives us an average trading volume of 769.02K if we extend that period to 3-months.

For Amneal Pharmaceuticals Inc. (AMRX), analysts’ consensus is at an average recommendation of an Overweight while assigning it a mean rating of 2.40. Splitting up the data highlights that, out of 7 analysts covering the stock, 1 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 4 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $0.2 in the current quarter.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored

Amneal Pharmaceuticals Inc. (NYSE:AMRX) trade information

Upright in the green during last session for gaining 0.65%, in the last five days AMRX remained trading in the green while hitting it’s week-highest on Tuesday, 01/11/22 when the stock touched $4.64 price level, adding 3.33% to its value on the day. Amneal Pharmaceuticals Inc.’s shares saw a change of -3.13% in year-to-date performance and have moved 0.22% in past 5-day. Amneal Pharmaceuticals Inc. (NYSE:AMRX) showed a performance of 12.08% in past 30-days. Number of shares sold short was 2.83 million shares which calculate 3.41 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $7.20 to the stock, which implies a rise of 35.56% to its current value. Analysts have been projecting $6.00 as a low price target for the stock while placing it at a high target of $8.00. It follows that stock’s current price would drop -72.41% in reaching the projected high whereas dropping to the targeted low would mean a loss of -29.31% for stock’s current value.

Amneal Pharmaceuticals Inc. (AMRX) estimates and forecasts

Statistics highlight that Amneal Pharmaceuticals Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company added 7.41% of value to its shares in past 6 months, showing an annual growth rate of 38.10% while that of industry is 16.80. Apart from that, the company came raising its revenue forecast for fiscal year 2022. This year revenue growth is estimated to rise 5.20% from the last financial year’s standing.

7 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $537.42 million for the same. And 2 analysts are in estimates of company making revenue of $506.2 million in the next quarter that will end on Mar 2022. Company posted $510.03 million and $493.11 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 5.40% while estimating it to be 2.70% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -17.50% during past 5 years. In 2022, company’s earnings growth rate is likely to be around 95.40% while estimates for its earnings growth in next 5 years are of -12.10%.

AMRX Dividends

Amneal Pharmaceuticals Inc. is more likely to be releasing its next quarterly report between February 24 and February 28 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

Amneal Pharmaceuticals Inc. (NYSE:AMRX)’s Major holders

Insiders are in possession of 10.75% of company’s total shares while institution are holding 69.17 percent of that, with stock having share float percentage of 77.49%. Investors also watch the number of corporate investors in a company very closely, which is 69.17% institutions for Amneal Pharmaceuticals Inc. that are currently holding shares of the company. Fosun International Ltd is the top institutional holder at AMRX for having 21.52 million shares of worth $114.92 million. And as of Sep 29, 2021, it was holding 14.41% of the company’s outstanding shares.

The second largest institutional holder is Tpg Group Holdings (sbs) Advisors, Inc., which was holding about 16.21 million shares on Sep 29, 2021. The number of shares represents firm’s hold over 10.85% of outstanding shares, having a total worth of $86.58 million.

>> 7 Top Picks for the Post-Pandemic Economy <<

On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 29, 2021, the former fund manager was holding 3.3 million shares of worth $17.61 million or 2.21% of the total outstanding shares. The later fund manager was in possession of 2.98 million shares on Sep 29, 2021, making its stake of worth around $15.91 million in the company or a holder of 2.00% of company’s stock.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

173226

100% free. stop anytime no spam